S&P Capital IQ Power Moves

CME Group announced that it has appointed Terrence Duffy, current executive chairman, to the expanded role of executive chairman and president, and has appointed current president Phupinder Gill to chief executive officer, replacing current CEO Craig Donohue. Both appointments are effective December 2012.

Duffy will continue to take a hands-on approach in the key external-facing functions of government relations, corporate marketing and communications, formalizing oversight of the areas in which he already is significantly involved.

Gill, who will report to Duffy, will be responsible for all other aspects of running the company, including clearing, technology & enterprise computing, global operations, enterprise solutions, products & services, legal & market regulation, research & product development, finance & corporate development, product marketing, and human resources. -PR Newswire

CME Group announced it has appointed William Knottenbelt to lead its Europe, Middle East and Africa (EMEA) regions, effective in mid-November 2011.

Robert Ray, who previously led the company’s international offices, will transition to a new role managing key strategic initiatives for CME Group in Europe and South America.

Both Knottenbelt and Ray will be based in London and will report to Bryan Durkin, CME Group chief operating officer and managing director, products & services.

Knottenbeltt, a 30-year veteran of the European financial services industry, will be responsible for developing customer relationships, core business growth and new business opportunities throughout the EMEA region. He served as global head of futures for the Royal Bank of Scotland (RBS) between 2000 and 2010 where he built out the global reach and product offering of RBS futures. He most recently served as global head of central counterparty clearing where he worked on developing the bank’s over-the-counter clearing solutions. He also held a number of leadership roles at RBS and its affiliates during the past 25 years, including global head of futures, FX and interest rate derivatives prime brokerage. He began his career trading commodities at C Czarnikow commodity trading house.

Ray, also a 30-year veteran of the financial services industry, has been based in London as managing director, international products & services since 2009. He previously led CME Group’s commodities and equities product lines and served as senior vice president, business development for the Chicago Board of Trade. He also worked in senior trading and derivatives business development roles with Robertson Stephens, Dean Witter Reynolds, Carr Futures and Continental Grain Company. -PR Newswire

CME Group announced the appointment of Michael Kilgallen as managing director, equity products.

Kilgallen, 39, will be responsible for advancing the growth strategy for the company’s equity index business line. He will be based in New York and will report to Scot Warren, managing director, equity index products and services.

Prior to joining the company, Kilgallen gained more than 15 years of experience in the global securities industry. He most recently served as managing director, global prime finance for Citigroup’s equities division. He also worked as vice president, portfolio manager and co-head of trading for the quantitative equity group within Goldman Sachs & Co.’s investment management division.

The company also appointed Sean Tully as managing director, interest rate products. He succeeds Robin Ross.

Tully, 47, will be responsible for leading and developing the company’s global interest rate business. He will be based in New York and will report to Derek Sammann, managing director, FX and interest rate products.

Tully’s financial services career spans more than 20 years, including most recently serving as managing director, global head of credit and fixed income trading at WestLB in London. -PR Newswire

CME Group announced that it has named Michel Everaert as managing director, OTC solutions. He will be based in London.

Everaert, 42, is responsible for overseeing OTC pre- and post-trade products. He will report to Laurent Paulhac, managing director, OTC products & services.

Before joining CME Group, Everaert served as chief information officer of IMEX Group. He also has served as CIO of e-commerce at GFI Group and held senior roles at Logica, Reuters and Dow Jones Telerate. -PR Newswire

CME Group has named Roger Rutherford as managing director, global head of FX products.

With 24 years of experience in the global FX marketplace, Rutherford will be responsible for leading the company’s global FX business line. He will be based in London and will report to Derek Sammann, managing director, FX and interest rate products.

Rutherford most recently served as head of product management for CLS Services London.

CME Group announced that it has named Michael C. Prokop as managing director, energy products.

With 25 years of global energy financial services experience, Prokop will be responsible for advancing the company’s growth strategy for its energy business line. He will be based in Houston and will report to Joe Raia, managing director, energy and metals products.

Prokop, 48, joins CME Group from Amerex Energy where he was responsible for the oversight and development of the company’s futures and clearing operations, data business and regulatory affairs. He also held leadership roles at FuturesSource, Gull Energy Finance Corporation and Eastbrook Futures, all based in Houston, and Merrill Lynch Futures based in New York. -PR Newswire

CME Group has named Craig J. Mohan as managing director, co-location and data center services.

In this newly created position, Mohan, 41, will be responsible for the strategic development, management and overall execution of the company’s co-location and data center hosting business, including sales, product development and client services. He will report to Julie Holzrichter, managing director, global operations.

Mohan joins CME Group from Citadel Investment Group where he served as director, global infrastructure and was responsible for managing the firm’s networking, technical architecture and global operations. -PR Newswire

CME Group announced the following managing director promotions, which were effective February 14, 2010:

Felix Carabello, 45, was prompted to managing director, energy and metals, international.

Carabello is responsible for executing company’s international energy and metals business strategy including increasing trading volume, managing client relationships and building product awareness. He will be based out of company’s ‘London office.

Prior to joining the company in 1999, Carabello held various trading and sales positions at Credit Lyonnaise Rouse and Griffin Trading.

Sam Coady, 45, was prompted to managing director, corporate finance.

Coady is responsible for financial valuations and business case development for mergers and acquisitions and strategic investments. He also manages competitor financial analysis and corporate finance special projects.

Prior to joining the company in 2001, Coady served in senior finance, internal audit and accounting roles for MarchFirst (formerly Whittman Hart) and Quaker Oats.

Elizabeth Gisch, 40, was prompted to managing director, global account management (GAM).

Gisch is responsible for leading company’s GAM team, which supports business development through relationships with strategic channel partners and acts as the primary contact for company’s customers in more than 80 countries worldwide. She also oversees the client side of new software releases and manages the customer development and connectivity processes for both CME Globex and the CME ClearPort Clearing API.

Gisch joined the company in 1993 and has held positions of increasing responsibility in the technology, products & services and global operations divisions since that time.

Matthew Kelly, 45, was prompted to managing director and associate general counsel.

Kelly is responsible for developing and managing CME Group’s intellectual property programs covering patents, trademark, copyrights, and trade secrets. He also manages strategic licensing, including product license agreements, out licensing of the company’s software and market data, intellectual property acquisitions and partnerships, and manages a variety of intellectual property litigation and enforcement matters.

David Lehman, 58, was prompted to managing director, commodity research & product development.

Lehman is responsible for leading efforts to identify and develop new company’s product and services opportunities related to both exchange-traded and over-the-counter (OTC) markets, maintaining viability of current product offerings and providing strategic insight into new markets, business development and research within the commodity space.

Prior to joining the company in 1989, Lehman held the position of industry economist with the Commodity Futures Trading Commission.

Brian McElligott, 37, was prompted to managing director, information products management.

McElligott is responsible for leading company’s market data business, including growing revenue generated from the sale and redistribution of CME Group market data assets. He also is responsible for leading most third-party licensing requirements, including CME Group’s credit default swap (CDS) initiative and the use of CME Group’s intellectual property in the creation of indices or structured products.

Prior to joining the company in 2001, McElligott worked as a technology consultant developing e-commerce sites and internet strategies for large financial institutions, including CME.

Brian Oliver, 39, was prompted to managing director, business development.

Oliver is responsible for leading company’s cleared OTC CDS initiative including strategy, business development and managing relationships with dealer and buy-side founding members.

Before joining the company, Oliver served as vice president for CRA International, an economics, finance and business consulting firm.

James V. Pieper, 43, was prompted to managing director, controller.

Pieper is responsible for ensuring the integrity of company’s public financial information and related disclosures including information for subsidiaries and affiliates. He also is responsible for ensuring the effectiveness of CME Group’s internal controls.

Before joining the company in 2004, Pieper worked for Divine as director of worldwide accounting and for KPMG as a senior manager.

Carl Stumpf, 41, was prompted to managing director and technology controller.

Stumpf serves as the financial controller for all CME Group technology spending and is responsible for accurate financial reporting for the company’s technology & enterprise computing division. He also leads the company’s technology budgeting process and supports major CME Group business initiatives including M&A and data center financial planning.

Before joining the company, Stumpf held technology development positions for Divine Professional Services, KPMG Consulting and Utilities International. -PR Newswire

CME Group announced several new senior leadership appointments to its legal & regulatory team.

Ann K. Shuman, managing director & deputy general counsel, has been promoted to an expanded role that will include legal support for regulatory policy initiatives and key growth activities. Shuman will continue reporting to Kathleen Cronin, managing director, general counsel and corporate secretary.

In her expanded role, Shuman, who has been with CME Group since 2000, will be responsible for leading the company’s legal function with respect to regulatory policy. Additionally, she will continue to oversee legal support for new business transactions, including negotiating and constructing strategic investments, partnerships and M&A activity.

Additionally, CME Group appointed Christopher K. Bowen as managing director, chief regulatory counsel. Bowen, will be responsible for overseeing the company’s domestic and international regulatory activities, including the development of new regulatory initiatives to support the recently announced CME Clearing Europe.

Bowen, who has been working with CME Group in a transitional capacity following the acquisition of NYMEX, most recently served as general counsel and chief administrative officer of NYMEX.

CME Group has also named Timothy W. Smith as managing director & associate general counsel. Smith, will be responsible for structuring and negotiating the company’s transactions including joint ventures, acquisitions and complex service agreements.

Prior to joining the company, Smith served as a partner in the corporate department at Winston & Strawn in Chicago, where one of his primary areas of focus was representing purchasers and sellers in complex acquisition, divestiture, merger and corporate restructuring transactions.

Both Bowen and Smith will report to Shuman. -PR Newswire

CME Group today announced that it has entered into a new employment agreement that provides for the continuation of chief executive officer Craig S. Donohue’s employment with CME Group for three additional years through December 31, 2012. In addition, the company announced that it has entered into a new employment agreement that provides for the continuation of president Phupinder Gill’s employment with CME Group for three additional years through December 31, 2013. Donohue, 47, has served as chief executive officer since January 2004 and joined the company in 1989. In addition, Donohue serves as a director of BM&FBOVESPA, chairman of the board of the Council for Economic Education, first vice chairman of the Executives’ Club of Chicago, and as a member of the Commodity Futures Trading Commission’s global markets advisory committee and the Wall Street Journal CEO council. He also serves as a director of the Managed Funds Association, the Chicago Council on Global Affairs and the Chicagoland Chamber of Commerce. In addition, he serves as vice chairman of the CME Group and NYMEX Foundations. Gill, 48, has served as president since January 2004 and joined the company in 1988. He serves as a director of Teach for America – Chicago, the Advisory Council for Youth Services of Glenview/Northbrook, Ill., and the CME Foundation. He also serves as a member of CME Group’s competitive markets advisory council. -PR Newswire

CME Group announced that Barry C. Goldblatt was named managing director, commodities, energy and metals, previously he was a director for Merrill Lyncha and David Boberski was named managing director, OTC research and new product development at the company.

CME Group announced that it has named David Boberski as managing director, OTC research and new product development. In this newly created position, Boberski, 33, will be responsible for identifying and developing new product opportunities in credit and interest rates, adapting existing CME Group products and services to the over-the-counter (OTC) markets and educating CME Group customers on CME Group credit and interest rate products.

He will report to Julie Winkler, managing director, research and product development. Prior to joining CME Group, Boberski most recently worked as a consulting expert for the U.S. Commodity Futures Trading Commission’s Division of Enforcement. He also has served as executive director and head of exchange traded derivatives research for UBS investment bank and managing director, principal and head of interest rate strategy for Bear Stearns where he gained extensive experience in OTC derivatives.-PR Newswire

CME Group announced the following corporate officer promotions, which were effective February 15, 2008. Danielle Dycus, 43, as managing director, Europe, Middle East and Africa.

David Hoag, 39, as managing director, clearing technology.

Kevin Lennon, 42, as managing director, real estate.

Christopher Mead, 41, as managing director, marketing.

Mark W. Bennett, Ellyn Burnett, Paul Callaway, and Cathy DeMille were appointed director, systems engineering. 

Thomas Boggs, 58, as director, equity products.

Dennis Cue, 35, as director, professional development and organizational effectiveness.

Charles Farra, 49, as director, international sales.

Mahesh Hira, 55, director, product management and operational solutions.

Ciby Kuruvilla, 37, as director, quality assurance.

Sachi Pati, Jim Skillen, and Ari Studnitzer were appointed director, software engineering.

Kathleen Wilcox, 35, as director, corporate initiatives group.

David Wong, 31, as director, enterprise risk management.

Jaime Yeh, 31, as director, product marketing.-PR Newswire

CME Group announced that it has named Michael Barston as director, equity products. barston, 49, will be responsible for supporting the development and execution of the company’s equity index futures and options product and marketing strategy and managing new and existing customer relationships to drive volume growth. He will be based in New York and will report to Scot Warren, CME Group managing director, equity products. Prior to joining CME Group, Barston gained more than fifteen years of global derivatives experience. He most recently served as senior relationship manager for Credit Suisse.-PR Newswire

CME Group announced that it has hired Pacy Ostroff as director, corporate strategy. In this newly created position, Ostroff, 43, will be responsible for helping to define, develop and implement the company’s corporate strategy as well as leading the development of strategic initiatives across existing and new lines of business. He will report to Jason Weller, managing director, corporate strategy.

Prior to joining CME Group, Ostroff most recently worked at Allstate Insurance where he led various growth strategy and business development initiatives.-PR Newswire

CME Group announced that it has named Marcus Katz as director, interest rate products. Katz, 47, will be responsible for expanding CME Group’s presence in the over-the-counter (OTC) interest rate market and growing the company’s global customer base. These responsibilities will include leading efforts to market CME Group’s benchmark interest rate products as tools to replicate OTC derivative transactions and developing new interest rate products and services related to the OTC markets.

He will report to Robin Ross, managing director, interest rate products. With more than 20 years of experience in the financial services industry, Katz most recently served as founder and managing partner of Winnemac Investments.-PR Newswire